Cargando…

Evidence-Based Medicine in the Field of Ophthalmology during the COVID-19 Pandemic

PURPOSE: To describe the evolution of COVID-19 related publications in the field of ophthalmology. METHODS: All articles published in the field of ophthalmology and relevant to COVID-19 were identified by conducting a search on PubMed and Scopus databases using the string ((ophthalmology) OR (eye) O...

Descripción completa

Detalles Bibliográficos
Autores principales: Walter, Eyal, Vofo, Brice, Jotkowitz, Alan, Levy, Jaime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968353/
https://www.ncbi.nlm.nih.gov/pubmed/35368998
http://dx.doi.org/10.1155/2022/3539134
_version_ 1784679027763576832
author Walter, Eyal
Vofo, Brice
Jotkowitz, Alan
Levy, Jaime
author_facet Walter, Eyal
Vofo, Brice
Jotkowitz, Alan
Levy, Jaime
author_sort Walter, Eyal
collection PubMed
description PURPOSE: To describe the evolution of COVID-19 related publications in the field of ophthalmology. METHODS: All articles published in the field of ophthalmology and relevant to COVID-19 were identified by conducting a search on PubMed and Scopus databases using the string ((ophthalmology) OR (eye) OR (ocular)) AND ((corona) OR (COVID-19) OR (pandemic)). Search was conducted on September 30, 2020. Each eligible publication was independently graded by two experienced ophthalmologists based on the level of evidence-based medicine (EBM), with scores ranging from 1 (the highest level of EBM) to 5 (the lowest level). The average level of EBM was also evaluated for each month from February through September. Finally, we analyzed the interval (in days) between submission and acceptance for publication as well as the percentage of manuscripts that required revision before being accepted. RESULTS: Our search yielded a total of 425 relevant publications. Of these publications, 359 (84.5%), 59 (13.9%), and 7 (1.6%) were rated as level 5, 4, and 3, respectively; none of the publications was rated as level 1 or 2. From February 2020 through September 2020, we found a significant increase in the relative proportion of level 3 and 4 publications compared to level 5 publications (rho = 0.108, p=0.024). Moreover, the number of citations per article was significantly correlated with the level of EBM (rho = 2.44, p < 0.0005); however, we found no correlation between the number of citations and either the month of publication or the ranking of the journal in which the article was published. The mean interval between submission and acceptance for publication was 20.4 days (SD: 20.2 days), and 48.2% of submitted manuscripts were accepted without revision. From February through September, the interval between submission and acceptance increased significantly (rho = 0.515, p < 0.0005); however, we found no significant change in the percentage of publications that were accepted without revision over this same time period. CONCLUSIONS: In the early months of the COVID-19 pandemic, primarily lower-level EBM articles were published, and these publications were accepted relatively quickly. However, this effect was temporary, and over time the EBM levels improved and the interval between submission and acceptance increased, indicating an increase in publication standards.
format Online
Article
Text
id pubmed-8968353
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-89683532022-04-01 Evidence-Based Medicine in the Field of Ophthalmology during the COVID-19 Pandemic Walter, Eyal Vofo, Brice Jotkowitz, Alan Levy, Jaime J Ophthalmol Research Article PURPOSE: To describe the evolution of COVID-19 related publications in the field of ophthalmology. METHODS: All articles published in the field of ophthalmology and relevant to COVID-19 were identified by conducting a search on PubMed and Scopus databases using the string ((ophthalmology) OR (eye) OR (ocular)) AND ((corona) OR (COVID-19) OR (pandemic)). Search was conducted on September 30, 2020. Each eligible publication was independently graded by two experienced ophthalmologists based on the level of evidence-based medicine (EBM), with scores ranging from 1 (the highest level of EBM) to 5 (the lowest level). The average level of EBM was also evaluated for each month from February through September. Finally, we analyzed the interval (in days) between submission and acceptance for publication as well as the percentage of manuscripts that required revision before being accepted. RESULTS: Our search yielded a total of 425 relevant publications. Of these publications, 359 (84.5%), 59 (13.9%), and 7 (1.6%) were rated as level 5, 4, and 3, respectively; none of the publications was rated as level 1 or 2. From February 2020 through September 2020, we found a significant increase in the relative proportion of level 3 and 4 publications compared to level 5 publications (rho = 0.108, p=0.024). Moreover, the number of citations per article was significantly correlated with the level of EBM (rho = 2.44, p < 0.0005); however, we found no correlation between the number of citations and either the month of publication or the ranking of the journal in which the article was published. The mean interval between submission and acceptance for publication was 20.4 days (SD: 20.2 days), and 48.2% of submitted manuscripts were accepted without revision. From February through September, the interval between submission and acceptance increased significantly (rho = 0.515, p < 0.0005); however, we found no significant change in the percentage of publications that were accepted without revision over this same time period. CONCLUSIONS: In the early months of the COVID-19 pandemic, primarily lower-level EBM articles were published, and these publications were accepted relatively quickly. However, this effect was temporary, and over time the EBM levels improved and the interval between submission and acceptance increased, indicating an increase in publication standards. Hindawi 2022-03-30 /pmc/articles/PMC8968353/ /pubmed/35368998 http://dx.doi.org/10.1155/2022/3539134 Text en Copyright © 2022 Eyal Walter et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Walter, Eyal
Vofo, Brice
Jotkowitz, Alan
Levy, Jaime
Evidence-Based Medicine in the Field of Ophthalmology during the COVID-19 Pandemic
title Evidence-Based Medicine in the Field of Ophthalmology during the COVID-19 Pandemic
title_full Evidence-Based Medicine in the Field of Ophthalmology during the COVID-19 Pandemic
title_fullStr Evidence-Based Medicine in the Field of Ophthalmology during the COVID-19 Pandemic
title_full_unstemmed Evidence-Based Medicine in the Field of Ophthalmology during the COVID-19 Pandemic
title_short Evidence-Based Medicine in the Field of Ophthalmology during the COVID-19 Pandemic
title_sort evidence-based medicine in the field of ophthalmology during the covid-19 pandemic
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968353/
https://www.ncbi.nlm.nih.gov/pubmed/35368998
http://dx.doi.org/10.1155/2022/3539134
work_keys_str_mv AT waltereyal evidencebasedmedicineinthefieldofophthalmologyduringthecovid19pandemic
AT vofobrice evidencebasedmedicineinthefieldofophthalmologyduringthecovid19pandemic
AT jotkowitzalan evidencebasedmedicineinthefieldofophthalmologyduringthecovid19pandemic
AT levyjaime evidencebasedmedicineinthefieldofophthalmologyduringthecovid19pandemic